{"id":"https://openalex.org/W2590243799","doi":"https://doi.org/10.1038/bjc.2017.36","title":"A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours","display_name":"A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours","alternate_titles":[],"publication_year":2017,"publication_date":"2017-02-21","ids":{"openalex":"https://openalex.org/W2590243799","doi":"https://doi.org/10.1038/bjc.2017.36","mag":"2590243799","pmid":"https://pubmed.ncbi.nlm.nih.gov/28222073","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5379148"},"language":"en","primary_location":{"id":"doi:10.1038/bjc.2017.36","doi":"https://doi.org/10.1038/bjc.2017.36","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.2017.36","pdf_url":"https://www.nature.com/articles/bjc201736.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2590243799"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/bjc201736.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050254542","display_name":"Richard H. Wilson","orcid":"https://orcid.org/0000-0001-8018-7730","observed_orcids":["https://orcid.org/0000-0001-8018-7730"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]},{"id":"https://openalex.org/I2802808109","display_name":"Belfast City Hospital","ror":"https://ror.org/02405mj67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1289110261","https://openalex.org/I2802808109"]},{"id":"https://openalex.org/I4210125479","display_name":"The Northern Ireland Cancer Centre","ror":"https://ror.org/030xykx52","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1289110261","https://openalex.org/I4210125479"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard H Wilson","raw_affiliation_strings":["Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7AE, UK","Northern Ireland Cancer Center, Belfast City Hospital, 51 Lisburn Road, Belfast BT9 7AB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7AE, UK","institution_ids":["https://openalex.org/I126231945"]},{"raw_affiliation_string":"Northern Ireland Cancer Center, Belfast City Hospital, 51 Lisburn Road, Belfast BT9 7AB, UK","institution_ids":["https://openalex.org/I2802808109","https://openalex.org/I4210125479"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108485804","display_name":"TR Jeffry Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"TR Jeffry Evans","raw_affiliation_strings":["Beatson West of Scotland Cancer Centre, and Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beatson West of Scotland Cancer Centre, and Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK","institution_ids":["https://openalex.org/I2800373718","https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051430596","display_name":"Mark Ross Middleton","orcid":"https://orcid.org/0000-0003-0167-1685","observed_orcids":["https://orcid.org/0000-0003-0167-1685"]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I34931013","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08","country_code":"GB","type":"government","lineage":["https://openalex.org/I34931013"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark R Middleton","raw_affiliation_strings":["National Institute for Health Research Biomedical Research Centre, Churchill Hospital, and Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute for Health Research Biomedical Research Centre, Churchill Hospital, and Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK","institution_ids":["https://openalex.org/I2801179840","https://openalex.org/I34931013","https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013897432","display_name":"L. Rhoda Molife","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L Rhoda Molife","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Downs Road, Sutton, Surrey, SM2 5PT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Downs Road, Sutton, Surrey, SM2 5PT, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034748028","display_name":"James F. Spicer","orcid":"https://orcid.org/0000-0003-3732-8491","observed_orcids":["https://orcid.org/0000-0003-3732-8491"]},"institutions":[{"id":"https://openalex.org/I1298207432","display_name":"Guy's Hospital","ror":"https://ror.org/04r33pf22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1298207432","https://openalex.org/I200166805","https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James Spicer","raw_affiliation_strings":["Division of Cancer Studies, King's College London, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cancer Studies, King's College London, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK","institution_ids":["https://openalex.org/I1298207432","https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056565799","display_name":"Veronique C Dieras","orcid":"https://orcid.org/0000-0001-8094-4738","observed_orcids":["https://orcid.org/0000-0001-8094-4738","https://orcid.org/0000-0002-8798-6540"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Veronique Dieras","raw_affiliation_strings":["Department of Medical Oncology, Institut Curie, 26, rue d'Ulm, Paris 75005 France","Department of Medical Oncology, Institut Curie, 26, rue d'Ulm, 75005, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Curie, 26, rue d'Ulm, Paris 75005 France","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"Department of Medical Oncology, Institut Curie, 26, rue d'Ulm, 75005, Paris, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052216285","display_name":"Patricia Roxburgh","orcid":"https://orcid.org/0000-0001-9869-591X","observed_orcids":["https://orcid.org/0000-0001-9869-591X"]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patricia Roxburgh","raw_affiliation_strings":["Beatson West of Scotland Cancer Centre, and Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beatson West of Scotland Cancer Centre, and Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK","institution_ids":["https://openalex.org/I2800373718","https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019014876","display_name":"Heidi Giordano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151488","display_name":"Clovis Oncology (United States)","ror":"https://ror.org/04ps4d441","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151488"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Heidi Giordano","raw_affiliation_strings":["Clovis Oncology, Inc., Boulder, 5500 Flatiron Parkway, Boulder, CO 80301, USA","Clovis Oncology, Inc., Boulder, 5500 Flatiron Parkway, Boulder, 80301, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clovis Oncology, Inc., Boulder, 5500 Flatiron Parkway, Boulder, CO 80301, USA","institution_ids":["https://openalex.org/I4210151488"]},{"raw_affiliation_string":"Clovis Oncology, Inc., Boulder, 5500 Flatiron Parkway, Boulder, 80301, CO, USA","institution_ids":["https://openalex.org/I4210151488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036460751","display_name":"Sarah Jaw\u2010Tsai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151488","display_name":"Clovis Oncology (United States)","ror":"https://ror.org/04ps4d441","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151488"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sarah Jaw-Tsai","raw_affiliation_strings":["Clovis Oncology, Inc., Boulder, 5500 Flatiron Parkway, Boulder, CO 80301, USA","Clovis Oncology, Inc., Boulder, 5500 Flatiron Parkway, Boulder, 80301, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clovis Oncology, Inc., Boulder, 5500 Flatiron Parkway, Boulder, CO 80301, USA","institution_ids":["https://openalex.org/I4210151488"]},{"raw_affiliation_string":"Clovis Oncology, Inc., Boulder, 5500 Flatiron Parkway, Boulder, 80301, CO, USA","institution_ids":["https://openalex.org/I4210151488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111964118","display_name":"Sandra M. Goble","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151488","display_name":"Clovis Oncology (United States)","ror":"https://ror.org/04ps4d441","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151488"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sandra Goble","raw_affiliation_strings":["Clovis Oncology, Inc., Boulder, 5500 Flatiron Parkway, Boulder, CO 80301, USA","Clovis Oncology, Inc., Boulder, 5500 Flatiron Parkway, Boulder, 80301, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clovis Oncology, Inc., Boulder, 5500 Flatiron Parkway, Boulder, CO 80301, USA","institution_ids":["https://openalex.org/I4210151488"]},{"raw_affiliation_string":"Clovis Oncology, Inc., Boulder, 5500 Flatiron Parkway, Boulder, 80301, CO, USA","institution_ids":["https://openalex.org/I4210151488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048419838","display_name":"Ruth Plummer","orcid":"https://orcid.org/0000-0003-0107-1444","observed_orcids":["https://orcid.org/0000-0003-0107-1444"]},"institutions":[{"id":"https://openalex.org/I2801924861","display_name":"Freeman Hospital","ror":"https://ror.org/00cdwy346","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801663869","https://openalex.org/I2801924861"]},{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ruth Plummer","raw_affiliation_strings":["Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, High Heaton, Newcastle Upon Tyne NE7 7DN, UK","Northern Institute for Cancer Research, Newcastle University, Paul O'Gorman Building, Framlington Place, Newcastle Upon Tyne NE2 4HH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, High Heaton, Newcastle Upon Tyne NE7 7DN, UK","institution_ids":["https://openalex.org/I2801924861"]},{"raw_affiliation_string":"Northern Institute for Cancer Research, Newcastle University, Paul O'Gorman Building, Framlington Place, Newcastle Upon Tyne NE2 4HH, UK","institution_ids":["https://openalex.org/I84884186"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":17,"corresponding_author_ids":["https://openalex.org/A5048419838"],"corresponding_institution_ids":["https://openalex.org/I2801924861","https://openalex.org/I84884186"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":5.0915,"has_fulltext":true,"cited_by_count":79,"citation_normalized_percentile":{"value":0.97010738,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"116","issue":"7","first_page":"884","last_page":"892"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rucaparib","display_name":"rucaparib","score":1.0},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.7940000295639038},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.8500000238418579},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8500000238418579},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6919999718666077},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8230000138282776},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9269999861717224},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7570000290870667},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9819999933242798},{"id":"https://openalex.org/keywords/brca1-mutation","display_name":"BRCA1 mutation","score":0.9240000247955322},{"id":"https://openalex.org/keywords/brca2-mutation","display_name":"BRCA2 mutation","score":1.0},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9760000109672546},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9760000109672546},{"id":"https://openalex.org/keywords/peritoneal-cancer","display_name":"peritoneal cancer","score":0.7459999918937683},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.9595259428024292},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8220959901809692},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.533186674118042},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5110548734664917},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45901599526405334},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4535771310329437},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4374723732471466},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39890027046203613},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.3466529846191406},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3337544798851013}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061605","descriptor_name":"Administration, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1038/bjc.2017.36","doi":"https://doi.org/10.1038/bjc.2017.36","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.2017.36","pdf_url":"https://www.nature.com/articles/bjc201736.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:ora.ox.ac.uk:uuid:9f264859-3da2-4583-8808-5cbbe034d7e2","doi":null,"is_oa":true,"landing_page_url":"https://ora.ox.ac.uk/objects/uuid:9f264859-3da2-4583-8808-5cbbe034d7e2","pdf_url":"https://ora.ox.ac.uk/objects/uuid:9f264859-3da2-4583-8808-5cbbe034d7e2/files/m8c53b4d8c78cfbb10d4b1ea6e33a545d","source":{"id":"https://openalex.org/S4306402636","display_name":"Oxford University Research Archive (ORA) (University of Oxford)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I40120149","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/I40120149"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Symplectic Elements at Oxford","raw_type":"Journal article"},{"id":"pmh:oai:pure.qub.ac.uk/portal:openaire/ca271e87-e326-4ffd-b389-e1914e9ce535","doi":null,"is_oa":true,"landing_page_url":"https://pure.qub.ac.uk/en/publications/ca271e87-e326-4ffd-b389-e1914e9ce535","pdf_url":"https://pure.qub.ac.uk/files/149102605/bjc201736.pdf","source":{"id":"https://openalex.org/S4306402319","display_name":"Research Portal (Queen's University Belfast)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126231945","host_organization_name":"Queen's University Belfast","host_organization_lineage":["https://openalex.org/I126231945"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Wilson, R, Evans, J, Middleton, M, Molife, L R, Spicer, J, Dieras, V, Roxburgh, P, Giordano, H, Jaw-Tsai , S, Goble, S & Plummer, R 2017, 'A phase 1 study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumors.', British Journal of Cancer, vol. 116, no. 7, pp. 884-892. https://doi.org/10.1038/bjc.2017.36","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:europepmc.org:4243222","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5379148","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5379148","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5379148/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:28222073","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28222073","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:kclpure.kcl.ac.uk:openaire/95bb3356-46b0-4179-a23e-2d3a6e078964","doi":null,"is_oa":true,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/95bb3356-46b0-4179-a23e-2d3a6e078964","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Wilson, R H, Evans, T J, Middleton, M R, Molife, L R, Spicer, J, Dieras, V, Roxburgh, P, Giordano, H, Jaw-Tsai, S, Goble, S & Plummer, R 2017, 'A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours', BJC: British Journal of Cancer, pp. 884-892. https://doi.org/10.1038/bjc.2017.36","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.gla.ac.uk:135114","doi":null,"is_oa":false,"landing_page_url":"https://eprints.gla.ac.uk/135114/","pdf_url":null,"source":{"id":"https://openalex.org/S7407122635","display_name":"Enlighten: Publications (University of Glasgow)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I7882870","host_organization_name":"University of Glasgow","host_organization_lineage":["https://openalex.org/I7882870"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Articles"}],"best_oa_location":{"id":"doi:10.1038/bjc.2017.36","doi":"https://doi.org/10.1038/bjc.2017.36","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.2017.36","pdf_url":"https://www.nature.com/articles/bjc201736.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G3178983131","display_name":null,"funder_award_id":"SPI/3315/06","funder_id":"https://openalex.org/F4320320853","funder_display_name":"Public Health Agency"},{"id":"https://openalex.org/G629414610","display_name":null,"funder_award_id":"12946","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G6400426949","display_name":null,"funder_award_id":"20409","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G6591838237","display_name":null,"funder_award_id":"11650","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320315087","display_name":"Clovis Oncology","ror":"https://ror.org/04ps4d441"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320320853","display_name":"Public Health Agency","ror":"https://ror.org/03ek62e72"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2590243799.pdf","grobid_xml":"https://content.openalex.org/works/W2590243799.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W182695913","https://openalex.org/W1847318561","https://openalex.org/W1879099940","https://openalex.org/W1973268287","https://openalex.org/W1976385056","https://openalex.org/W1982957001","https://openalex.org/W1989006164","https://openalex.org/W1991671417","https://openalex.org/W1992332625","https://openalex.org/W1994125700","https://openalex.org/W1994432408","https://openalex.org/W2002962154","https://openalex.org/W2009007206","https://openalex.org/W2019607817","https://openalex.org/W2039913198","https://openalex.org/W2043860312","https://openalex.org/W2046877602","https://openalex.org/W2059365987","https://openalex.org/W2066969492","https://openalex.org/W2072528578","https://openalex.org/W2077892030","https://openalex.org/W2096843793","https://openalex.org/W2098737737","https://openalex.org/W2100457669","https://openalex.org/W2106951948","https://openalex.org/W2110017381","https://openalex.org/W2111437716","https://openalex.org/W2114416638","https://openalex.org/W2116236442","https://openalex.org/W2117639046","https://openalex.org/W2128746885","https://openalex.org/W2131670056","https://openalex.org/W2134536765","https://openalex.org/W2135270007","https://openalex.org/W2137760882","https://openalex.org/W2147071985","https://openalex.org/W2153798189","https://openalex.org/W2165091409","https://openalex.org/W2168169655","https://openalex.org/W2168396953","https://openalex.org/W2171972386","https://openalex.org/W2173456459","https://openalex.org/W2179105349","https://openalex.org/W2308659819","https://openalex.org/W2529000802","https://openalex.org/W2557666746","https://openalex.org/W3093265161","https://openalex.org/W4253161128"],"related_works":["https://openalex.org/W2137714092","https://openalex.org/W2593067736","https://openalex.org/W182695913","https://openalex.org/W4399559514","https://openalex.org/W2597447452","https://openalex.org/W2982510276","https://openalex.org/W2064695479","https://openalex.org/W1984087886","https://openalex.org/W2308659819","https://openalex.org/W2975028605"],"abstract_inverted_index":{"This":[0],"study":[1,43],"evaluated":[2],"safety,":[3],"pharmacokinetics,":[4],"and":[5,10,71,84,100,113,134,157,181],"clinical":[6],"activity":[7],"of":[8,31,92,195],"intravenous":[9,32],"oral":[11,49,118,132],"rucaparib,":[12],"a":[13,90,152,191],"poly(ADP-ribose)":[14],"polymerase":[15],"inhibitor,":[16],"combined":[17,34,55,189],"with":[18,22,35,56,89,116,190,199],"chemotherapy":[19],"in":[20,60,68,73,175,197],"patients":[21,27,77,198],"advanced":[23,200],"solid":[24,201],"tumours.":[25],"Initially,":[26],"received":[28],"escalating":[29],"doses":[30],"rucaparib":[33,50,133,148,185],"carboplatin,":[36],"carboplatin/paclitaxel,":[37],"cisplatin/pemetrexed,":[38],"or":[39,177],"epirubicin/cyclophosphamide.":[40],"Subsequently,":[41],"the":[42,104,117,125,138],"was":[44,127],"amended":[45],"to":[46],"focus":[47],"on":[48],"(once":[51],"daily,":[52],"days":[53],"1\u201314)":[54],"carboplatin":[57,135,165,196],"(day":[58],"1)":[59],"21-day":[61],"cycles.":[62,75],"Dose-limiting":[63],"toxicities":[64,110],"(DLTs)":[65],"were":[66,78,103,114,162],"assessed":[67],"cycle":[69],"1":[70],"safety":[72],"all":[74],"Eighty-five":[76],"enrolled":[79],"(22":[80],"breast,":[81],"15":[82],"ovarian/peritoneal,":[83],"48":[85],"other":[86],"primary":[87],"cancers),":[88],"median":[91],"three":[93],"prior":[94],"therapies":[95],"(range,":[96],"1\u20137).":[97],"Neutropenia":[98],"(27.1%)":[99],"thrombocytopenia":[101],"(18.8%)":[102],"most":[105],"common":[106],"grade":[107],"\u2a7e":[108],"3":[109],"across":[111],"combinations":[112],"DLTs":[115],"rucaparib/carboplatin":[119,168],"combination.":[120],"Maximum":[121],"tolerated":[122],"dose":[123,194],"for":[124],"combination":[126,169],"240":[128],"mg":[129,141],"per":[130],"day":[131],"area":[136],"under":[137],"curve":[139],"5":[140],"ml":[142],"\u22121":[143,145],"min":[144],".":[146],"Oral":[147,184],"demonstrated":[149],"dose-proportional":[150],"kinetics,":[151],"long":[153],"half-life":[154],"(\u224817":[155],"h),":[156],"good":[158],"bioavailability":[159],"(36%).":[160],"Pharmacokinetics":[161],"unchanged":[163],"by":[164],"coadministration.":[166],"The":[167],"had":[170],"radiologic":[171],"antitumour":[172],"activity,":[173],"primarily":[174],"BRCA1-":[176],"BRCA2":[178],"-mutated":[179],"breast":[180],"ovarian/peritoneal":[182],"cancers.":[183],"can":[186],"be":[187],"safely":[188],"clinically":[192],"relevant":[193],"tumours":[202],"(Trial":[203],"registration":[204],"ID:":[205],"NCT01009190).":[206]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2590243799","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-03-03T00:00:00"}
